MedTrace Logo

30-Minute Light Exposure for the Treatment of Seasonal Affective Disorder

NCT01462305 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2019-01-30

Study results available
· View outcomes & findings →

Summary

The primary objective of this study is to evaluate the effect of light therapy using a narrow 467nm light compared to a 580nm light in subjects with Seasonal Affective Disorder (SAD). It is hypothesized that the 467nm light will improve the symptoms of SAD better than the 580nm light.

Conditions

  • Seasonal Affective Disorder

Interventions

DEVICE

goLITE

goLITE at 30 minutes per day, within 30 minutes of waking in the morning

DEVICE

Control

light therapy using 580nm LED source within 30 minutes of waking in the morning every day for 6 weeks

Sponsors & Collaborators

  • Philips Respironics

    lead INDUSTRY

Principal Investigators

  • Janis Anderson, PhD · Brigham and Women's Hospital

  • Robert Auger, MD · Mayo Clinic

  • Scott Crow, MD · University of Minnesota

  • Carol Glod, PhD · Mclean Hospital

  • Alfredo Rivera, MD · Community Research Management Associates

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-06
Primary Completion
2012-04-02
Completion
2012-04-02

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01462305 on ClinicalTrials.gov